Nanoparticles play an essential role in biomedical applications, such as drug delivery, bio sensing, and tissue engineering. They guarantee the delivery of drugs to the target tissues. The controlled release mechanisms improve the efficacy and safety of the treatments. Further, Nano-based methods have been developed where cancer therapies are integrated with diagnostic imaging techniques, offering hope for combined or integrated treatments in the future. Over the past decade, tremendous research has revolutionized drug delivery systems by focusing on delivering therapeutic agents and natural active compounds directly to the targeted site for the treatment of various diseases. Although the prevailing drug delivery systems have found immense applications, problems including drug stability, bioavailability, and precise targeting continue to persist. Such limitations open up avenues for more advanced technologies to emerge to discover higher efficacy and safety of the therapy. Nano-based drug delivery systems have emerged as promising options in improving the solubility and controlled-release delivery of drugs and targeted site delivery. By encapsulating therapeutics within Nano carriers, it shields therapeutic agents from degradation while ensuring their delivery to the target site and thereby minimizing the side effects with maximum effectiveness. Nanotechnology is now in the pipeline day by day in search of the precise aspect of its potential in medicine, promising to make a revolution in chronic and complex diseases into more efficient and personalized therapies. This bolds a promising treatment of vast diseases as medicine is destined for further progressions in NDDS. Nanotechnology shall thus be able to revolutionize the delivery method in a way that drugs would be administered in more effective manner, personalized, and therefore reachable to patients all over the world.
Sharma* et al. (2026) studied this question.